Alberto Yáñez

Dr. Alberto Yáñez

Departamento de Microbiología y Ecología, and Estructura de Recerca Interdisciplinar en Biotecnologia i Biomedicina (ERI BIOTECMED), Universitat de València, Burjassot, Spain
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2014 in Cell Host & Microbe
Verified
Journal Article
Closed access
AKArya Khosravi
Arya Khosravi
Alberto YáñezAlberto Yáñez
Alberto Yáñez
JPJeremy G. Price
Jeremy G. Price
ACAndrew Chow
Andrew Chow
MMMiriam Merad
Miriam Merad
SMSarkis K. Mazmanian
Sarkis K. Mazmanian

18 March 2016 in Science
Verified
Journal Article
Closed access
PDF file
JOJ. G. O’rourke
J. G. O’rourke
LBL. Bogdanik
L. Bogdanik
Alberto YáñezAlberto Yáñez
Alberto Yáñez
DLD. Lall
D. Lall
AWA. J. Wolf
A. J. Wolf
RBR. H. Baloh
R. H. Baloh
Linking neurodegeneration and immune cells: The expansion of a repetitive DNA sequence in the C9orf72 gene is the major genetic cause of amyotrophic lateral sclerosis and frontotemporal dementia. Although the expansion decreases C9orf72 expression, most research has focused on the toxic RNA and protein products it creates in neurons. O'Rourke et al. found that C9orf72 unexpectedly plays a key role in innate immune cells. Loss of C9orf72 in mice led to macrophage and microglial dysfunction and age-related neuroinflammation. This raises the possibility of a “dual-effect” disease mechanism, in which toxic byproducts in neurons are combined with microglial dysfunction from decreased C9orf72 expression, together promoting neurodegeneration. Science , this issue p. 1324

1 November 2017 in Immunity
Verified
Journal Article
Closed access
Alberto YáñezAlberto Yáñez
Alberto Yáñez
SCSimon G. Coetzee
Simon G. Coetzee
AOAndre Olsson
Andre Olsson
DMDavid E. Muench
David E. Muench
BBBenjamin P. Berman
Benjamin P. Berman
HGHelen S. Goodridge
Helen S. Goodridge

19 August 2020 in Nature
Verified
Journal Article
Closed access
PDF file
MMMadelyn E. McCauley
Madelyn E. McCauley
JOJacqueline Gire O’rourke
Jacqueline Gire O’rourke
Alberto YáñezAlberto Yáñez
Alberto Yáñez
JMJanet L. Markman
Janet L. Markman
RHRitchie Ho
Ritchie Ho
RBRobert H. Baloh
Robert H. Baloh

17 July 2019 in Frontiers in Immunology
Verified
Journal Article
Open access
AWAnja A. Wolf
Anja A. Wolf
Alberto YáñezAlberto Yáñez
Alberto Yáñez
PBPijus K. Barman
Pijus K. Barman
HGHelen S. Goodridge
Helen S. Goodridge
Classical and non-classical monocytes, and the macrophages and monocyte-derived dendritic cells they produce, play key roles in host defense against pathogens, immune regulation, tissue repair and many other processes throughout the body. Recent studies have revealed previously unappreciated heterogeneity among monocytes that may explain this functional diversity, but our understanding of mechanisms controlling the functional programming of distinct monocyte subsets remains incomplete. Resolving monocyte heterogeneity and understanding how their functional identity is determined holds great promise for therapeutic immune modulation. In this review, we examine how monocyte origins and developmental influences shape the phenotypic and functional characteristics of monocyte subsets during homeostasis and in the context of infection, inflammation, and cancer. We consider how extrinsic signals and transcriptional regulators impact monocyte production and functional programming, as well as the influence of epigenetic and metabolic mechanisms. We also examine the evidence that functionally distinct monocyte subsets are produced via different developmental pathways during homeostasis and that inflammatory stimuli differentially target progenitors during an emergency response. We highlight the need for a more comprehensive understanding of the relationship between monocyte ontogeny and heterogeneity, including multiparametric single-cell profiling and functional analyses. Studies defining mechanisms of monocyte subset production and maintenance of unique monocyte identities have the potential to facilitate the design of therapeutic interventions to target specific monocyte subsets in a variety of disease contexts, including infectious and inflammatory diseases, cancer, and aging.

26 November 2018 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
MRMirja Rotinen
Mirja Rotinen
SYSungyong You
Sungyong You
JYJulie Yang
Julie Yang
SCSimon G. Coetzee
Simon G. Coetzee
MRMariana Reis-Sobreiro
Mariana Reis-Sobreiro
MFMichael R. Freeman
Michael R. Freeman